Mutations in the FGFR4 gene (5q35.2) lead to modifications at K535 and E550 in the kinase domain of the FGFR4 protein in breast cancer patients, causing protein autophosphorylation and activation. The gene discussed is FGFR4; the disease is breast cancer.